8 Sept 2026Open access
Beyond CA-125: circulating cell-free DNA as the next-generation biomarker in ovarian malignancyPublisher siteBMC Cancer, Cancer Genomics and Diagnostics
Active, last published 2026
In liver disease diagnosis and treatment
Naglaa
Elabd
Scholar“Research focused on Liver Disease Diagnosis and Treatment and adjacent fields.”
Menoufia University
Egypt
Claim Your ProfileEgypt6
H-index
103
Citations
Naglaa has not officially claimed their profile. If you are Naglaa, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
aglaa Elabd is a researcher working on Liver Disease Diagnosis and Treatment. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Naglaa's work has been cited 103 times across 3 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Liver Disease Diagnosis and Treatment×15Hepatitis C virus research×9Liver Disease and Transplantation×7COVID-19 Clinical Research Studies×4MicroRNA in disease regulation×4
04 · Where I am
Affiliations
Affiliation on published researchMenoufia University, EgyptDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
10 works1 Apr 2026Open access
The Prognostic Impact of Supraclavicular Lymph Node Metastases in Lung Cancer: Do We Need a Modification of the Current Staging System?Publisher siteAsian Pacific Journal of Cancer Prevention, Lung Cancer Diagnosis and Treatment
3 Jul 2024Open access
Frequency of spontaneous bacterial peritonitis among cirrhotic ascitic patients and predictors for its outcome in Menoufia University HospitalsPublisher siteMicrobes and Infectious Diseases /Microbes and Infectious Diseases, Liver Disease and Transplantation
15 Jun 2024Open access
Bile level of cytokeratin 7 as a diagnostic marker for cholangiocarcinoma: a case-control study in Egyptian patientsPublisher siteEgyptian Liver Journal, Cholangiocarcinoma and Gallbladder Cancer Studies
30 May 2024Open access7cites
Metabolic profiling during COVID-19 infection in humans: Identification of potential biomarkers for occurrence, severity and outcomes using machine learningPublisher sitePLoS ONE, Metabolomics and Mass Spectrometry Studies
4 May 2024Open access4cites
FURIN, IFNL4, and TLR2 gene polymorphisms in relation to COVID-19 severity: a case–control study in Egyptian patientsPublisher siteInfection, COVID-19 Clinical Research Studies
21 Jan 2024Open access1cites
Cytokines profile and their related genotypes in COVID-19: Correlation with disease severity and outcome in Egyptian patientsPublisher siteMicrobes and Infectious Diseases /Microbes and Infectious Diseases, COVID-19 Clinical Research Studies
1 Jan 2024Open access2cites
Insights into the Correlation between Toll‐Like Receptor 2 Polymorphism and HBV‐Related Disease Progression and Occurrence of Hepatocellular Carcinoma: A Case‐Control Study in Egyptian PatientsPublisher siteCanadian Journal of Infectious Diseases and Medical Microbiology, Hepatitis B Virus Studies
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Naglaa?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you